Clinical practice guidelines for the management of sporotrichosis: 2007 update by the Infectious Diseases Society of America
about
Sporothrix schenckii and SporotrichosisUse of potassium iodide in dermatology: updates on an old drugMelanins Protect Sporothrix brasiliensis and Sporothrix schenckii from the Antifungal Effects of TerbinafineCytotoxicity and anti-Sporothrix brasiliensis activity of the Origanum majorana Linn. oilSporothrix schenckii COMPLEX:SUSCEPTIBILITIES TO COMBINED ANTIFUNGAL AGENTS AND CHARACTERIZATION OF ENZYMATIC PROFILESSporotrichal Tenosynovitis Diagnosed Helpfully by Musculoskeletal Ultrasonography.Minimal inhibitory concentration distributions and epidemiological cutoff values of five antifungal agents against Sporothrix brasiliensis.Genetic diversity and antifungal susceptibility profiles in causative agents of sporotrichosis.Sporotrichosis in a liver transplant patient: A case report and literature review.Clinical hepatotoxicity associated with antifungal agents.Sporotrichosis: an overview and therapeutic optionsThe difficult management of disseminated Sporothrix brasiliensis in a patient with advanced AIDSEpidemiological investigation of an outbreak of cutaneous sporotrichosis, Northern Territory, AustraliaEfficacy of posaconazole in murine experimental sporotrichosisFixed cutaneous sporotrichosis treated with topical amphotericin B in an immune suppressed patient.Sporotrichosis in renal transplant patients.Adamantylidene-substituted alkylphosphocholine TCAN26 is more active against Sporothrix schenckii than miltefosine.Sporotrichosis-Associated Hospitalizations, United States, 2000-2013The Upside of Bias: A Case of Chronic Meningitis Due to Sporothrix Schenckii in an Immunocompetent Host.Treatment of endemic mycoses.Use of Antifungal Combination Therapy: Agents, Order, and Timing.Infection and panniculitis.Managing fungal and viral infections in pediatric leukemia.Mycoses of implantation in Latin America: an overview of epidemiology, clinical manifestations, diagnosis and treatment.Antifungal prophylaxis and therapy in patients with hematological malignancies and hematopoietic stem cell transplant recipients.Amphotericin B use in children: conventional and lipid-based formulations.Cutaneous sporotrichosis: a six-year review of 19 cases in a tertiary referral center in Malaysia.Pulmonary sporotrichosis: case series and systematic analysis of literature on clinico-radiological patterns and management outcomes.Epidemiology of sporotrichosis in Venezuela.Itraconazole: an update on pharmacology and clinical use for treatment of invasive and allergic fungal infections.Invasive candidiasis: update on current pharmacotherapy options and future perspectives.Dimorphic fungal osteoarticular infections.Fungal infections of the skin and nail: new treatment options.Multicenter, International Study of MIC/MEC Distributions for Definition of Epidemiological Cutoff Values for Sporothrix Species Identified by Molecular Methods.In vitro susceptibility of Sporothrix brasiliensis: Comparison of yeast and mycelial phases.Critical review of current clinical practice guidelines for antifungal therapy in paediatric haematology and oncology.Sporotrichosis as an unusual case of osteomyelitis: A case report and review of the literature.In Vitro Antifungal Susceptibility of Yeast and Mold Phases of Isolates of Dimorphic Fungal Pathogen Emergomyces africanus (Formerly Emmonsia sp.) from HIV-Infected South African Patients.Δ(24)-Sterol Methyltransferase Plays an Important Role in the Growth and Development of Sporothrix schenckii and Sporothrix brasiliensis.Unusual clinical presentation of sporotrichosis in three members of one family.
P2860
Q24635012-7D007F52-E8BC-485A-99E4-353B86CED9C3Q26862965-F3A3C6F6-7D1A-4075-8205-779445474ED8Q28551102-F9D54D25-35A2-45A8-B01E-B0307D4AF14FQ28822473-7070B3AA-9655-4ACC-BB82-7FF9127EF082Q30999502-137E72A5-A0BA-4AC9-A92A-76C4B35E9300Q32182031-ECB2F08C-265D-42A6-B89A-6D83978A8598Q33583405-1A8F7B58-EB91-4C73-BF25-B7FBB44B6A93Q33611290-88D6CBC8-1E9A-4C1E-B24B-F6AA13F749F2Q33838082-EF48CC08-3017-45BE-B471-6487C4A7D6ABQ34546811-0700A088-6F7B-4B02-98B8-C732AAB1A8CCQ34968193-7F4687AC-3D5E-41E0-9148-596153934C6FQ35576213-A790061A-96CC-4686-8DFF-79BE83FCE318Q35892221-F1685A63-8C8C-4482-B89C-2E843B6A9F0EQ35941465-D53B5659-9207-452D-8EE8-2E9BED601701Q37009789-963CEF59-94F9-4B4A-B26F-1B2074A36DB8Q37037334-B83DE266-244C-4A79-9A72-05BD566965B6Q37167710-93DE6476-01D0-43D2-9337-3B4C77C549AFQ37288116-A3771672-0E5C-44ED-883B-B3B869E1636BQ37514657-2ECB0768-F63B-4436-B87E-705FA07E16C2Q37729998-115BA9BE-DAF3-47D3-BC3B-D1AEA9A53E66Q37767359-59EA208B-630B-4A3C-8207-AD43E5793183Q37776289-2AD52818-9905-49BE-A974-34303A9335F3Q37810281-11DFA4D4-EF5C-40BA-807E-6402A807B953Q37815477-140B51EA-3EAC-4962-9F8C-E1AF36E74DEFQ37816399-EE68EF67-3A0D-4736-8B12-2305A1C6E49AQ37854727-CE227A8C-F079-4765-9369-92A50A8643F5Q38011244-9B464498-066B-4AEA-9EB2-600388CF2225Q38071336-A8E5214E-D051-4BE1-B4E3-F93F6EDC6A25Q38102003-6F9AD0F0-049B-42C6-BA70-126BDA453754Q38103889-08670432-6E9D-4DA7-8977-2D59DAB6DE11Q38110850-B9FA9F0B-4A2F-4E64-92B4-06FF4971CDE1Q38221100-FCF1BB27-34DF-40A3-93CF-6FD4A8A64D40Q38252946-11C322B8-E60F-4557-9F5C-C73CC1EBBFD4Q38663717-0B5C4340-50BA-4894-927B-F1181EF18F05Q38803958-677FEAF1-2163-440E-97F7-2DDEE7258528Q38822532-91F08D1B-6CFD-4090-BA23-0D2CDE1340D8Q38829495-0B3DCFCF-F52F-4557-915E-D2147063427BQ38868375-BE038441-F1B9-4D29-955D-2F4314CF4F74Q38913538-4359AFF2-48C4-464F-B2A0-37C9ACA6B157Q38998444-431A1C98-04BD-4182-93A6-8B820D08DB2E
P2860
Clinical practice guidelines for the management of sporotrichosis: 2007 update by the Infectious Diseases Society of America
description
2007 nî lūn-bûn
@nan
2007 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Clinical practice guidelines f ...... us Diseases Society of America
@ast
Clinical practice guidelines f ...... us Diseases Society of America
@en
Clinical practice guidelines f ...... us Diseases Society of America
@nl
type
label
Clinical practice guidelines f ...... us Diseases Society of America
@ast
Clinical practice guidelines f ...... us Diseases Society of America
@en
Clinical practice guidelines f ...... us Diseases Society of America
@nl
prefLabel
Clinical practice guidelines f ...... us Diseases Society of America
@ast
Clinical practice guidelines f ...... us Diseases Society of America
@en
Clinical practice guidelines f ...... us Diseases Society of America
@nl
P2093
P2860
P3181
P356
P1476
Clinical practice guidelines f ...... us Diseases Society of America
@en
P2093
Beatriz Bustamante
Carol A Kauffman
Peter G Pappas
Stanley W Chapman
P2860
P304
P3181
P356
10.1086/522765
P407
P577
2007-11-15T00:00:00Z